Tseng, L., Liu, C., Chang, K., Chu, P., Shiau, C., & Chen , K. (2012). CIP2A is a target of bortezomib in human triple negative breast cancer cells. BioMed Central.
Citação norma ChicagoTseng, Ling-Ming, Chun-Yu Liu, Kung-Chi Chang, Pei-Yi Chu, Chung-Wai Shiau, and Kuen-Feng Chen. CIP2A Is a Target of Bortezomib in Human Triple Negative Breast Cancer Cells. BioMed Central, 2012.
Citação norma MLATseng, Ling-Ming, et al. CIP2A Is a Target of Bortezomib in Human Triple Negative Breast Cancer Cells. BioMed Central, 2012.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.